04/11/2024
3:21 PM | Esperion Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:19 PM | Esperion Therapeutics (Filer)
| Form ARS | |
03/15/2024
3:30 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:32 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:33 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:34 PM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:35 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/27/2024
8:19 AM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:23 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:14 PM | CVI Investments, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
9:50 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
02/14/2024
7:42 AM | Deep Track Capital, LP (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
5:11 AM | Esperion Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
2:46 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
2:21 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
5:04 AM | Esperion Therapeutics (Filer)
| Form 424B5 | |
01/22/2024
5:10 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
4:01 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/11/2024
3:09 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
10:02 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A | |
01/03/2024
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
7:52 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:30 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
8:00 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G | |
09/21/2023
4:06 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
2:22 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023
3:17 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
08/24/2023
8:29 AM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/21/2023
3:32 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
2:31 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023
8:02 AM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2023
7:51 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
6:07 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
3:38 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
2:32 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023
5:03 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
3:45 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
2:24 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:07 PM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:08 PM | CARROLL J MARTIN (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:08 PM | Esperion Therapeutics (Issuer)
Fischer Seth H. Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
What is Medicare Supplement Insurance? (Ad) Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.  Learn More Here |
06/16/2023
3:09 PM | Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:09 PM | Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
12:25 PM | BlackRock Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
05/25/2023
3:39 PM | Esperion Therapeutics (Filer)
| Form DEFA14A | |
05/17/2023
3:40 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
8:00 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:22 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
8:26 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
